Profiles of plasma serpins in patients with advanced malignant melanoma, gastric cancer and breast cancer

Haemostasis

Volumn 28, Issue 1, 1998, Pages 7-13

  Wojtukiewicz, M Z ^a   Rucinska M ^a   Kloczko, J ^a   Dib, A ^a   Galar, M ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Breast cancer; Coagulation fibrinolysis inhibitors; Gastric cancer; Malignant melanoma; Serpins

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 1 ANTITRYPSIN; ALPHA 2 ANTIPLASMIN; ALPHA 2 MACROGLOBULIN; ANTITHROMBIN III; BLOOD CLOTTING FACTOR 13A; COMPLEMENT COMPONENT C1S INHIBITOR; FIBRIN; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; FIBRONECTIN; SERINE PROTEINASE INHIBITOR;

ARTICLE; BLOOD CLOTTING; BLOOD LEVEL; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; FIBRINOLYSIS; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; PROTEINASE INHIBITION; STOMACH CANCER; THROMBOSIS;

EID: 0032431831     PISSN: 03010147     EISSN: None     Source Type: Journal    
DOI: 10.1159/000022376     Document Type: Article

References (29)

1. Bick RI: Coagulation abnormalities in malignancy: A review. Semin Thromb Hemost 1992;18:353-372.
2. Nand S: Hemostasis and cancer. Cancer J 1993;6:54-58.
3. Donati MB: Cancer and thrombosis. Haemostasis 1994;24:128-131.
4. 1-Antitrypsin and the serpins: Variation and countervariation. Trends Biochem Sci 1985;10:20.
5. Rubin H: Serine protease inhibitors (SERPINS): Where mechanism meets medicine. Nat Med 1996;2:632-633.
6. Laurell CB: Quantitative estimation of proteins by electrophoresis in aga-rose gel containing antibodies. Anal Biochem 1966;15:45-52.
7. Folin O, Ciocalteau V: Tyrosine and tryptophan determination in proteins. J Biol Chem 1927;73:627-650.
8. Lorand L, Urayama T, de Kiewiet JWC, Nossel HL: Diagnostic and genetic studies of fibrin-stabilizing factor with a new assay based on amine incorporation. J Clin Invest 1969;48:1054-1064.
9. Merskey C, Larezari P, Johnson AJ: A rapid, simple, sensitive method for measuring of fibrinolytic split products in human serum. Proc Soc Exp Biol Med 1969;131:871-875.
10. Rickles FR, Edwards RL: Activation of blood coagulation in patients with cancer. Trousseau's syndrome revisited. Blood 1983;62:14-31.
11. Zacharski LR, Wojtukiewicz MZ, Costantini V, Ornstein DL, Memoli VA: Pathways of coagulation/fibrinolysis activation in malignancy. Semin Thromb Hemost 1992;18:104-116.
12. Zacharski LR, Costantini V: Blood coagulation activation in cancer: Challenges for cancer treatment. Hämostaseologie 1995;15:14-20.
13. 1-antitrypsin in gastric cancer patients. Nippon Shokakibyo Gakkai Zasshi 1993;90:2873-2881.
14. 1-antichymotrypsin in the sera of patients with gastrointestinal cancers during diagnosis. Cancer 1988;62:1188-1193.
15. Roeise O, Siversten S, Ruud TE, Bouma BN, Stadaas JO, Aasen AO: Studies on components of the contact phase system in patients with advanced gastrointestinal cancer. Cancer 1990;65:1355-1359.
16. Petersen CM, Jensen PH, Bukh A, Sunde L, Lamm LU, Ingerslev J: Pregnancy zone protein: A re-evaluation of serum levels in healthy women and in women suffering from breast cancer or thromboplastic disease. Scand J Clin Lab Invest 1990;50:479-485.
17. Abbasciano V, Tassinari D, Sartori S, Trevisani L, Arcudi D, Bianchi MP, Liboni A: Usefulness of coagulation markers in staging of gastric cancer. Cancer Detect Prev 1995;19:331-336.
18. 1-Antitrypsin in human brain tumors. J Neurosurg 1987;67:258-262.
19. Latner AL, Turner GA, Lamin MM: Plasma alpha-1-antitrypsin levels in early and late carcinoma of the cervix. Oncology 1976;33:12-14.
20. Hasegawa H, Aiba K: Significance of cancer-related serum proteins in patients with gynecologic neoplasms. Yokohama Med Bull 1983;34:185-191.
21. Stracca-Pansa V, Menegon A, Donisi PM, Bozzola L, Fedeli F, Quarto F, Nappi O, Pettinato G: Gastric carcinoma with osteoclast-like giant cells. Report of four cases. Am J Clin Pathol 1995;103:453-459.
22. 1-Antitrypsin and anchorage-independent growth of MCF-7 breast cancer cells. Endocrinology 1993;133:966-1002.
23. Kelly UL, Cooper EH, Alexander C, Stone J: The assessment of antichymotrypsin in cancer monitoring. Biomedicine 1978;28:209-215.
24. 1-antitrypsin. J Biol Chem 1976;251:4514.
25. 2-macroglobulin and growth factors in human melanoma cell lines. J Cell Biochem 1990;43:315-325.
26. Gilead Z, Zahari R, Hatzubai A, Brufman G, Biran S, Sulitzeanu D: Levels of fibrinogen/fibrin degradation fragment E and related substances in sera and effusion of pa-tients with malignant disease. J Cancer Res Clin Oncol 1983;106:195-201.
27. Zacharski LR, Memoli VA, Rousseau SM, Kisiel W: Occurrence of blood coagulation factors in situ in small cell carcinoma of the lung. Cancer 1987;60:2675-2681.
28. Doran JE: A critical assessment of fibronectin's opsonic role for bacteria and microaggregates. Vox Sang 1983;45:337-348.
29. Wojtukiewicz MZ, Zacharski LR, Moritz TE, Hur K, Edwards RL, Rickles FR: Prognostic significance of blood coagulation tests in carcinoma of the lung and colon. Blood Coagul Fibrinolysis 1992;3:429-437.